Int Arch Otorhinolaryngol 2012; 16(04): 523-526
DOI: 10.7162/S1809-97772012000400015
Case Report
Thieme Publicações Ltda Rio de Janeiro, Brazil

Laryngeal Leishmaniasis

Bruno Teixeira de Moraes
1   ENT. Master in Health Sciences Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo.
,
Francisco de Souza Amorim Filho
2   Head and Neck Surgeon. PhD in Health Sciences Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo.
,
José Caporrino Neto
3   ENT. Assistant Professor, Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo.
,
Paulo Saraceni Neto
4   Medical. Resident Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo.
,
José Elson Santiago de Melo Júnior
5   Physician. Specializing Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo.
› Author Affiliations
Further Information

Publication History

07 August 2010

24 October 2010

Publication Date:
10 December 2013 (online)

Summary

Introduction: Leishmaniasis is classified into three clinical presentations: visceral, coetaneous and mucocutaneous. The latter is usually secondary to hematogenous spread after months or years of skin infection and can manifest as infiltrative lesions, ulcerated or vegetating in nose, pharynx, larynx and mouth, associated or not with ganglionics infarction. Laryngeal involvement is part of the differential diagnosis of lesions in this topography as nonspecific chronic laryngitis, granulomatosis and even tumors of the upper aerodigestive tract presenting atypical evolution. Sometimes it is difficult for the correct diagnosis of Leishmaniasis, with description of cases in the literature were conducted improperly.

Objective: The objective of this study is to report a case of laryngeal Leishmaniasis addressing the difficulty of diagnosis, complications and treatment applied.

Case Report: A patient with pain throat, dysphagia, odynophagia, dysphonia and weight loss, with no improvement with symptomatic medication. At telelaringoscopy, infiltrative lesion showed nodular supraglottis. He underwent a tracheotomy for airway obstruction and biopsy with immunohistochemical study for a definitive diagnosis of laryngeal Leishmaniasis. The patient was referred to the infectious diseases that initiated treatment with N-methylglucamine antimoniate with satisfactory response to therapy.

Final Comments: Faced with a clinical suspicion of granulomatous diseases, it is essential to follow protocol laboratory evaluation associated with histological injury, to get a precise definition etiological without prolonging the time of diagnosis. Medical treatment for mucosal Leishmaniasis, recommended by the World Health Organization, was adequate in the case of laryngeal disorders, with complete resolution of symptoms.

 
  • References

  • 1 Manual de Vigilância da Leishmaniose Tegumentar Americana. 2a. ed. Brasília: Editora do Ministério da Saúde; 2007
  • 2 Grant A, Spraggs PD, Grant HR, Bryceson AD. Laryngeal leishmaniasis. J Laryngol Otol 1994; 108 (12) 1086-1088
  • 3 David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther 2009; 22 (6) 491-502
  • 4 Sizeland A. Leishmaniosis in third world. N Engl J Med 1995; 332 (9) 610-1
  • 5 Lightfoot Stanley A. J Am Board Fam Pract 1997; 10 (5) 374-6
  • 6 Ravisse P, Bensimon P, Lapicorey G. A case of laryngeal leishmaniasis with a long course. Bull Soc Pathol Exot Filiales 1984; May-Jun; 77 (3) 305-11
  • 7 Lessa MM , et al. Leishmaniose Mucosa: aspectos clínicos e epidemiológicos. Braz J Otorhinolaryngol 2007; 73 (6) 843-847
  • 8 Carvalho T, Dolci JEL. Avaliação clínica da influência do uso de glucantine em pacientes com Leishmaniose nasal. Acta ORL 2006; 24 (2) 77-82
  • 9 Caporrino Neto J, Cervantes O, Jotz GP, Abrahão M. Doenças granulomatosas da Laringe. Acta Awho 1998; 17 (1) 6-10
  • 10 World Health Organization (WHO). The Leishmaniases: report of a WHO Expert Committee. Geneva, 1984. (Technical Report Series; 701).